Cite
HARVARD Citation
Maouche, N. et al. (2023). Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort. Journal of oncology pharmacy practice. pp. 299-304. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maouche, N. et al. (2023). Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort. Journal of oncology pharmacy practice. pp. 299-304. [Online].